CARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2 mg/mL) in GALAXY Single-Dose Container, Manufactured and Marketed by: Baxter Healthcare Corporation, Dee Recall
Ongoing
Drugs
Class II — Moderate
Recall Date
Sep 9, 2026
Company
Baxter Healthcare Corporation
Source
FDA
Units
N/A
Reason: CGMP Deviations
Official FDA recall noticeInformation is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.
Recall Details
Description
CGMP Deviations
Reason for Recall
CGMP Deviations
What Should I Do?
Quantity: N/A
Remediation GuideAction Required
5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.
1
Confirm Your Product Is Affected2
Read the Full Recall Notice3
Stop Using the Product if in Doubt+2 more steps…
Last updated September 15, 2026
Injured by a recalled product?
Our legal partners offer free consultations for recall victims.
Stay Informed
Weekly recall digest — free, no spam.